Regulation of ligands for the activating receptor NKG2D.
about
Human NKG2D-ligands: cell biology strategies to ensure immune recognitionWiskott-Aldrich syndrome protein (WASp) and N-WASp are involved in the regulation of NK-cell migration upon NKG2D activationEndogenous retinoids in the pathogenesis of alopecia areataCrystal Structure of the Cowpox Virus-Encoded NKG2D Ligand OMCPHuman IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cellsImmunoprofiling of Adult-Derived Human Liver Stem/Progenitor Cells: Impact of Hepatogenic Differentiation and InflammationChimeric NKG2D T cells require both T cell- and host-derived cytokine secretion and perforin expression to increase tumor antigen presentation and systemic immunity.Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivoInduction of ATM/ATR pathway combined with Vγ2Vδ2 T cells enhances cytotoxicity of ovarian cancer cellsThe human herpesvirus-7 (HHV-7) U21 immunoevasin subverts NK-mediated cytoxicity through modulation of MICA and MICBGenomic analysis reveals pre- and postchallenge differences in a rhesus macaque AIDS vaccine trial: insights into mechanisms of vaccine efficacyChemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells.Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells.Soluble ligands for the NKG2D receptor are released during endometriosis and correlate with disease severity.NF-κB regulates MICA gene transcription in endothelial cell through a genetically inhibitable control site.Polymeric delivery of therapeutic RAE-1 plasmid to the pancreatic islets for the prevention of type 1 diabetes.Viral antigen mediated NKp46 activation of NK cells results in tumor rejection via NK-DC crosstalk.NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell PhenotypePotential for enhanced therapeutic activity of biological cancer therapies with doxycycline combinationLine of attack: NK cell specificity and integration of signals.Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicityCutting edge: down-regulation of MHC class I-related chain A on tumor cells by IFN-gamma-induced microRNANKG2D ligands in tumor immunity.Proteasome regulation of ULBP1 transcription.Association of MICA gene polymorphisms with liver fibrosis in schistosomiasis patients in the Dongting Lake region.Natural killer cells: integrating diversity with function.Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy CellsNatural killer cell cytotoxicity: how do they pull the trigger?Structural basis for recognition of cellular and viral ligands by NK cell receptors.The anti-tumor role of NK cells in vivo pre-activated and re-stimulated by interleukins in acute lymphoblastic leukemia.Regulation of self-ligands for activating natural killer cell receptors.Therapeutic gene delivery using bioreducible polymers.Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor ActivityAssociations of MICA Polymorphisms with Inflammatory Rheumatic Diseases.The nuclear factor-κB pathway down-regulates expression of the NKG2D ligand H60a in vitro: implications for use of nuclear factor-κB inhibitors in cancer therapy.5'-UTR and 3'-UTR Regulation of MICB Expression in Human Cancer Cells by Novel microRNAsMYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma.Role of NKG2D in cytokine-induced killer cells against lung cancer.Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.A dual function of NKG2D ligands in NK-cell activation.
P2860
Q21131219-D0D927C5-F809-45A0-A817-83240853184FQ24322081-4C5A94D9-C5E6-4576-8C33-97DF9C234538Q24632863-8E23F9A9-2238-40D4-8618-FEAB18ACE2F7Q27674864-D93A8B84-7C2D-4869-B6D0-3554F38949B2Q33522918-E4F62D46-67BD-4FB7-BC80-74A818242587Q33604750-E02B4F6A-1F0D-4AA7-9813-D97FC062D7C2Q33671322-4B1216D5-A133-4209-8A0D-242810CE6697Q33725633-7473BD90-0D3B-4972-B0B1-4BB8114DE94DQ33849537-273BE6A4-FE85-4065-B901-123C3DB7EF11Q34079158-A19B0BE8-E59E-4B4B-A7AA-1FF0250FA252Q34485178-964096C1-41FA-488F-81EB-2DF7C46129BFQ34700290-B17BDF3F-20C4-494D-8436-EBD12CD29FB6Q34855104-9DA5C2AB-2529-4EA6-9B81-131D476BB870Q35181683-6CE0A39E-5C62-424D-B65D-349FDFF5AC89Q35763310-0AA0FEBF-A884-4398-AEF4-CCBB524B1030Q36269185-A20641A1-BA7C-4A6B-A35C-FBF3C4536696Q36373365-753B477D-93C2-4EEF-91AB-334216FFAB56Q36660550-FC551C8C-AF88-4F17-B7A7-2F1F44037660Q36750814-3C899AF0-7C06-4196-A5E8-16DDCC4BB830Q36930253-DF8FE1B2-6B75-4C35-93A7-78974CFED636Q37081973-7A657FF2-78CE-416A-9BAA-56CFFD82449DQ37271077-DA8F6369-1D0A-4FB3-8806-6BE756EF2A4FQ37287179-3D62ADFD-9F74-4BFB-85D5-9BC6AF4302D6Q37357720-30D86AA3-2C2C-4659-9EE8-9CAE47383021Q37370889-5646F79B-1A0B-4A69-ACDC-209A2DDA709FQ37412618-6E24CC18-15BE-4AED-96F8-74E049A42D86Q37559284-7BB68AEE-156E-4A43-80A9-4A1935AE7572Q37582007-4FDA9278-B29D-46D4-ABF5-D777991F16A7Q37678862-09835F04-E5D5-43A3-9ABB-C8EC03D0C3DCQ37694772-8BC05868-8406-4992-822A-EA683FC90F2CQ38108820-38AAFD3F-C302-4426-8E53-BF92510025EAQ38157750-0BEBF2AB-5CDA-4D98-9160-27D99DF67476Q38203261-DF7391F5-D103-4E2C-9F88-D0D0AB91D57EQ38257969-327B10FA-C5BF-4048-806C-AC6415966F8CQ38318217-14BFC1C6-37B2-4A63-A043-977BC42BFF97Q38604052-33825A04-9E30-49F1-8CA2-D9662CF77146Q38697986-6DECAC75-A616-4F07-91BB-CF67829ED75DQ38772095-5E8EB08C-5B95-4845-9292-40195206C0FAQ39176227-E4C91FA9-4C58-4999-952E-8C61322B746AQ39323944-90AC0ADC-9781-43F4-BE67-52270D41BB05
P2860
Regulation of ligands for the activating receptor NKG2D.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Regulation of ligands for the activating receptor NKG2D.
@en
type
label
Regulation of ligands for the activating receptor NKG2D.
@en
prefLabel
Regulation of ligands for the activating receptor NKG2D.
@en
P2860
P1433
P1476
Regulation of ligands for the activating receptor NKG2D.
@en
P2093
Anita R Mistry
Chris A O'Callaghan
P2860
P304
P356
10.1111/J.1365-2567.2007.02652.X
P577
2007-08-01T00:00:00Z